Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics US
December 13 - 16, 2026
Marriott Marquis San Diego

Nichole Escalante, PhD
Senior Scientist and Group Lead at Zymeworks
Speaker

Profile

Dr. Nichole Escalante earned her PhD in Immunology from the University of Toronto and completed postdoctoral training at Stanford University, focusing on immune cell-engaging therapies for cancer and autoimmunity.

She is a Senior Scientist and Group Lead of the In Vivo Pharmacology and Pharmacokinetics team within Zymeworks' Multispecific Antibody Therapeutics department. She provides scientific and strategic leadership in the preclinical evaluation of antibody- and cytokine-based therapeutics, overseeing assay and model development to characterize therapeutic activity and pharmacokinetics. She also leads cross-functional therapeutic development efforts, shaping preclinical strategy and driving the advancement of novel therapeutic candidates.

Agenda Sessions

  • Engineering Conditional Co-stimulation: Key Considerations for Developing Next-Generation T Cell Engagers

    , 1:45pm